Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.

J Bone Oncol · 2017 · PMC5294742 · PMID 28194325

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

a statistical trendp=0.083so close (0.05 < p ≤ 0.1)

Despite this difference, only a statistical trend was noted favoring those patients with negative sYB-1, both in the univariate (p=0.083) and multivariate analysis (controlling for age at diagnosis, hormone receptor status and presence of extra-bone metastases; HR 1.64, 95% CI 0.68–3.99, p=0.272).

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.